My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 237

    1.

    Narrative review: a rational approach to starting insulin therapy.

    Mooradian AD, Bernbaum M, Albert SG.

    Ann Intern Med. 2006 Jul 18;145(2):125-34. Review.PMID: 16847295 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

    DeWitt DE, Hirsch IB.

    JAMA. 2003 May 7;289(17):2254-64. Review.PMID: 12734137 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

    Ilag LL, Kerr L, Malone JK, Tan MH.

    Clin Ther. 2007;29 Spec No:1254-70. Review.PMID: 18046926 [PubMed - indexed for MEDLINE]Related articles

    4.

    The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.

    Baxter MA.

    Acta Diabetol. 2008 Dec;45(4):253-68. Epub 2008 Sep 3. Review.PMID: 18766296 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.

    Ulrich H, Snyder B, Garg SK.

    Vasc Health Risk Manag. 2007;3(3):245-54. Review.PMID: 17703632 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

    Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.

    Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. Review.PMID: 17443605 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?

    Bell DS.

    Drugs. 2007;67(13):1813-27. Review.PMID: 17722952 [PubMed - indexed for MEDLINE]Related articles

    8.

    [An update on multiple insulin injection therapy in type 1 and 2 diabetes]

    Varanauskiene E, Varanauskaite I, Ceponis J.

    Medicina (Kaunas). 2006;42(9):770-9. Review. Lithuanian. PMID: 17028476 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Refining basal insulin therapy: what have we learned in the age of analogues?

    Devries JH, Nattrass M, Pieber TR.

    Diabetes Metab Res Rev. 2007 Sep;23(6):441-54. Review.PMID: 17668418 [PubMed - indexed for MEDLINE]Related articles

    10.

    Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.

    Kinsley B.

    Clin Ther. 2007;29 Suppl D:S153-60. Review.PMID: 18191067 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Insulin therapy]

    Brunetti P.

    Minerva Endocrinol. 2001 Jun;26(2):65-86. Review. Italian. PMID: 11479436 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.

    Miles HL, Acerini CL.

    Paediatr Drugs. 2008;10(3):163-76. Review.PMID: 18454569 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost-effectiveness of insulin analogues for diabetes mellitus.

    Cameron CG, Bennett HA.

    CMAJ. 2009 Feb 17;180(4):400-7.PMID: 19221353 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Insulin detemir--a new basal insulin analog.

    Goldman-Levine JD, Lee KW.

    Ann Pharmacother. 2005 Mar;39(3):502-7. Epub 2005 Jan 18. Review.PMID: 15657117 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin analogues: new dimension of management of diabetes mellitus.

    Siddiqui NI.

    Mymensingh Med J. 2007 Jan;16(1):117-21. Review.PMID: 17344794 [PubMed - indexed for MEDLINE]Related articles

    16.

    Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.

    Raja-Khan N, Warehime SS, Gabbay RA.

    Vasc Health Risk Manag. 2007;3(6):919-35. Review.PMID: 18200811 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Dosing of insulin glargine in the treatment of type 2 diabetes.

    Barnett A.

    Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

    18.

    Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects?

    Valensi P, Cosson E.

    Diabetes Metab. 2005 Sep;31(4 Pt 2):4S34-4S39. Review.PMID: 16389896 [PubMed - indexed for MEDLINE]Related articles

    19.

    Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus.

    Mullins P, Sharplin P, Yki-Jarvinen H, Riddle MC, Haring HU.

    Clin Ther. 2007 Aug;29(8):1607-19.PMID: 17919543 [PubMed - indexed for MEDLINE]Related articles

    20.

    Subcutaneous insulin: pharmacokinetic variability and glycemic variability.

    Guerci B, Sauvanet JP.

    Diabetes Metab. 2005 Sep;31(4 Pt 2):4S7-4S24. Review.PMID: 16389894 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity